INTRODUCTION: Macular pigment plays an important role in the reduction of oxidative stress and in preventing retinal diseases. Quick and easy measurements of the macular pigment are essential in both clinical and research settings. Dual wavelength fundus auto-fluorescence seems to be the optimal method. This study aims to investigate changes in fundus autofluorescence in patients taking daily lutein oral supplements and develop image processing methods for follow-up evaluations of the images. METHODS: New devices allow us to examine fundus autofluorescence using both blue and green excitation wavelengths. This allows detection of the amount of macular pigment by subtracting these two images because the yellow pigment particles absorb blue wavelengths. We determined daily dose of 25 mg of lutein and 3 mg of zeaxanthin. Patients were followed up for 15 months at 3-month intervals. RESULTS: During our 15-month study, we observed a positive trend in pixel lightness values, suggesting an increase in macular pigments in the foveal area. In all patients taking daily lutein supplements, the foveal index significantly increased after six months, with a median change of 0.081. We did not observe a significant change after the first three months (0.006) and only a small change between the 6th and 12th-month visits (0.012). CONCLUSION: With appropriate patients and procedures for capturing autofluorescence images, this is a valuable technique for macular pigment evaluation in follow-up examinations using software image post-processing and analysis with commonly available hardware. To put this into everyday practice, developing tools to automate the assessment is necessary.

Department of Ophthalmology UJEP Masaryk Hospital Krajska zdravotni a s Usti nad Labem Czech Republic

Department of Ophthalmology University Hospital Kralovske Vinohrady and 3rd Faculty of Medicine Charles University Prague Prague Czech Republic

Zobrazit více v PubMed

Snodderly DM, Brown PK, Delori FC, Auran JD. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 1984;25(6):660-73.

Li B, Ahmed F, Bernstein PS. Studies on the singlet oxygen scavenging mechanism of human macular pigment. Arch Biochem Biophys 2010;504(1):56-60. DOI

Nolan JM, Power R, Stringham J, Dennison J, Stack J, Kelly D, Moran R, Akuffo KO, Corcoran L, Beatty S. Enrichment of Macular Pigment Enhances Contrast Sensitivity in Subjects Free of Retinal Disease: Central Retinal Enrichment Supplementation Trials - Report 1. Invest Ophthalmol Vis Sci 2016;57(7):3429-39. doi: 10.1167/iovs.16-19520 PubMed DOI

Craft NE, Haitema TB, Garnett KM, Fitch KA, Dorey CK. Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J Nutr Health Aging 2004;8(3):156-62.

Nolan JM, Loskutova E, Howard A, Mulcahy R, Moran R, Stack J, Bolger M, Coen RF, Dennison J, Akuffo KO, Owens N, Power R, Thurnham D, Beatty S. The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial. J Alzheimers Dis 2015;44(4):1157-69. doi: 10.3233/JAD-142265 PubMed DOI

Lindbergh CA, Renzi-Hammond LM, Hammond BR, Terry DP, Mewborn CM, Puente AN, Miller LS. Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial. J Int Neuropsychol Soc 2018;24(1):77-90. doi: 10.1017/S1355617717000534 PubMed DOI

AREDS2 Research Group; Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, Sperduto R, Ferris FL. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology 2012;119(11):2282-9. doi: 10.1016/j.ophtha.2012.05.027 PubMed DOI

Charbel Issa P, van der Veen RL, Stijfs A, Holz FG, Scholl HP, Berendschot TT. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. Exp Eye Res 2009;89(1):25-31. DOI

Srinivasan R, Teussink MM, Sloan KR, Bharat RPK, Narayanan R, Raman R. Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity. BMC Ophthalmol 2022;22(1):264. DOI

Zeimer MB, Krömer I, Spital G, Lommatzsch A, Pauleikhoff D. Macular telangiectasia: patterns of distribution of macular pigment and response to supplementation. Retina 2010;30(8):1282-93. DOI

Roberts JE, Dennison J. The Photobiology of Lutein and Zeaxanthin in the Eye. J Ophthalmol 2015;2015:687173. DOI

Reiter GS, Schwarzenbacher L, Schartmüller D, Röggla V, Leydolt C, Menapace R, Schmidt-Erfurth U, Sacu S. Influence of lens opacities and cataract severity on quantitative fundus autofluorescence as a secondary outcome of a randomized clinical trial. Sci Rep 2021;11(1):12685. doi: 10.1038/s41598-021-92309-6 PubMed DOI

Boettner EA, Reimer Wolter J. Transmission of the Ocular Media. Invest Ophthalmol Vis Sci 1962;1(6):776-83.

US DFU ClareonTM Aspheric Hydrophobic Acrylic IOL with the AutonoMeTM Automated Pre-loaded Delivery System Model: CNA0T0, Rev. 0120, Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf19/P190018C.pdf

Eom Y, Suh YW, Kim SW, Lee YJ, Jeon HS, Lee SY, Lee IH, Song JS, Kim HM. New technology using crystalline lens autofluorescence for presbyopia and cataract grading. Graefes Arch Clin Exp Ophthalmol 2023;261(7):1923-32. doi: 10.1007/s00417-023-05999-1 PubMed DOI

Loskutova E, Butler JS, Hernandez Martinez G, Flitcroft I, Loughman J. Macular Pigment Optical Density Fluctuation as a Function of Pupillary Mydriasis: Methodological Considerations for Dual-Wavelength Autofluorescence. Curr Eye Res 2021;46(4):532-8. DOI